Tinzaparin is a low-molecular-weight heparin (LMWH) with antithrombotic properties. It has FDA-approved labeling for use in the treatment of acute symptomatic deep-vein thrombosis (DVT ...

with typical doses of heparin (5,000 U for a 70 kg patient) expected to result in adequate anticoagulation. However, weight-based nomograms to guide heparin dosing may reduce the incidence of ...